Request Download SampleCompany Profile New Jersey, United States,- The Market Research Intellect report predicts that the Hematopoietic Stem Cells Transplantation Market will find players focused on new product development in order to secure a solid position in terms of revenue distribution.
DUBLIN, Feb. 9, 2021 /PRNewswire/ -- The "Cell Therapy Market by Cell Type, Therapy Type, Therapeutic Area, and End User: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering
Gamida Cell Ltd., a maker of cell and immune therapy technologies, on Wednesday published the results of a key late-stage clinical trial of its flagship drug, which aims to increase the success of bone marrow transplants in blood cancer patients triggering a surge in its Nasdaq-traded shares. Gamidas shares jumped almost 26% on the US exchange Wednesday. The shares have advanced 163% in the past 12 months, leading to a company valuation of $733 million.
The global stem cell therapy market is expected to witness a CAGR of 10.6% during the forecast period 2019-2024, and is also anticipated to reach USD 214.5 million by 2024.
Global Stem Cell Banking Market Research Report: By Cell Type (Umbilical Cord Stem Cells, Adult Stem Cells, Embryonic Stem Cells), By Bank Type (Private Banks, Public Banks, Hybrid Banks) and By Application (Thalassemia, Cerebral Palsy, Diabetes, Leukemia, Autism, Others) Forecast to 2025 Market Highlights According to MRFR analysis,Stem Cell Banking Marketis expected to register a CAGR of 9.8% during the forecast period of 2019 to 2025 and is expected to reach USD 12,056.7 Million by 2025. Stem cells (SC) are a class of undifferentiated biological cells of a multicellular organism that have the ability to produce indefinite cells of the same type, from which certain types of cells (proliferation and replication) can be produced by differentiation in the body through early life and growth
The stock price of Gamida Cell Ltd (NASDAQ: GMDA) an advanced cell therapy company committed to cures for blood cancers and serious hematologic diseases is trading over 40% pre-market as of 6:52 AM ET. Investors are responding to Gamida Cell announcing the results of a Phase 3 clinical study of omidubicel presented in an oral session at the Transplantation & Cellular Therapy Meetings of the American Society of Transplantation and Cellular Therapy (ASTCT) and Center for International Blood & Marrow Transplant Research (CIBMTR), or the TCT Meetings. Omidubicel is an advanced cell therapy under development as a potential life-saving allogeneic hematopoietic stem cell transplant solution for patients with hematologic malignancies
The report titled Stem Cell Banking Market by Source (PSCs, hESCs, BMSCs, ADSCs, and Others), by Application (Personalized Banking, Clinical, and Research), and by Service Type (Sample Collection & Transportation, Sample Processing, Sample Analysis, and Sample Preservation & Storage): Global Industry Perspective, Comprehensive Analysis, and Forecast, 20182025 utilizing diverse methodologies aims to examineand put forth in-depth and accurate data regarding the globalStem Cell Banking Market.To begin with, the report comprises the major players actively participating and competing within theStem Cell Banking Market; it entails several companies, manufacturers, suppliers, organizations, and so on. Thus, the report will assist in understanding the initiatives and approaches implemented by these players to create and reinforce their market presence.The report is segregated into different well-defined sections to provide the reader with an easy and understandable informational document.
Global Hematopoietic Stem Cell Transplantation (HSCT) Report offers market size, share, overview, segmentation by types, application, countries, key manufactures, cost analysis, industrial chain, sourcing strategy, downstream buyers, marketing strategy analysis, distributors/traders, factors affecting market, forecast and other important information for key insight. The research report on Hematopoietic Stem Cell Transplantation (HSCT) market is an in-depth analysis of pivotal drivers, challenges, and growth prospects prevailing in the business space and their impact on the expansion graph over the ensuing years. Request a sample Report of Hematopoietic Stem Cell Transplantation (HSCT) Market at:https://www.marketstudyreport.com/request-a-sample/3147041?utm_source=algosonline.com&utm_medium=Ram According to the report, Hematopoietic Stem Cell Transplantation (HSCT) market is anticipated to record a y-o-y growth rate of XX% over the analysis duration (2020-2026) and is poised to amass substantial revenues by the end of study term.
MarketQuest.biz offers a detailed research study on Global Hematopoietic Stem Cells Transplantation Market 2020 by Company, Type and Application, Forecast to 2025 which is a professional detailing of the important elements that drive the market growth rate and revenue statistics. The report exhibits comprehensive information that is a valuable source of insightful data for business strategists during the decade 2015-2025.
India Stem Cell Market to surpass huge revenue of USD 1.27 Billion at CAGR +13% by 2028. Stem cell therapy in India helps in treating several diseases, including leukaemia, lymphoma, thalassemia, Parkinsons, Alzheimers, stroke, cerebral palsy, spinal cord injury, muscular dystrophy, etc. Stem cell therapy in India has shown promising results in India and as well as all over the world
Recent Comments